Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Brace for More Declines by Occidental Petroleum

By Chris Lau, InvestorPlace Contributor
Occidental Petroleum depends too much, like any other energy firm, on a rebound of oil prices which may or may not come.

Avoid Inovio Pharmaceuticals Like the Plague

By Lou Carlozo, InvestorPlace Contributor
The pharma is pursuing a Covid-19 vaccine. But INO stock is risky as the company has failed to bring a product to market for 40 years.

Stand Clear as the Bull Case for Workhorse Stock Continues to Get Thinner

By Muslim Farooque, InvestorPlace Contributor
Workhorse Group's dismal financial positioning, ineffective intellectual properties and poor margins make WKHS stock a risky bet.

The Core Problem with Landcadia Holdings II Stock

By Vince Martin, InvestorPlace Contributor
Unlike other online gambling plays, LCA stock has an intriguing fundamental case. But those fundamentals highlight a precarious competitive position.

Marathon Oil Stock Doesn’t Look as If It’s Going Anywhere Anytime Soon

By Larry Sullivan, InvestorPlace contributor
Investors should be very cautious about oil companies in this time of the Covid-19 pandemic. MRO stock is no exception.

7 AI Stocks With More Hype Than Bite

By Vince Martin, InvestorPlace Contributor
Many investors are looking for the best AI stocks to buy right now. But these seven names don't quite make the cut.

Don’t Gamble on Sorrento Stock

By Thomas Yeung, CFA, InvestorPlace Markets Analyst
SRNE stock buyers beware. Company management has long targeted unsuspecting biotech investors in never-ending game of fundraising.

Don’t Head for Heartache With Hertz Stock

By Todd Shriber, InvestorPlace Contributor
Bankrupt and saddled with more debt than it can probably handle, HTZ stock is a losing ticket for most investors right now.

Time to Call ‘Lights Out’ on General Electric

By Lou Carlozo, InvestorPlace Contributor
While General Electric boasts status as a founding Dow Jones company, GE stock today is a bet simply not worth the risk.

DiamondPeak Stock Really Looks Quite Risky Here

By Larry Ramer, InvestorPlace Contributor
DiamondPeak stock looks like a risky investment, given the strength of Lordstown's competitor, Rivian, and Lordstown's close connections with Workhorse.

Steer Clear of ‘Stuck In Neutral’ General Electric Stock

By InvestorPlace Research Staff
Between pandemic headwinds, and a turnaround that's still a work-in-progress, there's not much reason to buy GE stock right now.

The Ship Has Already Sailed Far Away for Workhorse Stock

By Thomas Niel, InvestorPlace Contributor
With its Lordstown and Post Office catalysts fully priced-in, there's no reason to buy the pullback in WKHS stock.

Coca-Cola Is Treading Water, But It’s Still Too Expensive

By Mark R. Hake, CFA
Coca-Cola stock has gone nowhere for five years but its still expensive. It is up 7% annually over five years, but still at 24x earnings.

Hertz Stock Is Only Good for Deliberately Hurting Your Portfolio

By InvestorPlace Research Staff
Hertz stock was once a brief contrarian play for the extreme gambler. But now that the fundamentals are settling in, it’s best to avoid this nightmarish “opportunity.”

Don’t Get Silly When Looking at General Electric

By Chris Markoch, InvestorPlace Contributor
GE stock has been making large moves, mostly based on hopes for more economic stimulus. But any news, good or bad, is baked into the stock.

There Are Really Long Odds That Tilray Stock Makes a Comeback Soon

By Larry Ramer, InvestorPlace Contributor
The still-high valuation of Tilray stock, coupled with the sector's continued structural challenges, make the stock unattractive.

The Risk-to-Reward Proposition for Sorrento Has Gone Bad

By Will Ashworth, InvestorPlace Contributor
Sorrento Therapeutics shareholders witnessed SRNE stock gain 70% in the past month. The risk-to-reward proposition has gone from good to bad.   

When to Sell a Stock

By Louis Navellier, Editor, Growth Investor
When a stock's fundamentals are slipping, wait for an opportunity to sell into strength. Whenever you can, resist the urge to panic-sell a stock.

Investors Will Eventually Grow Tired of Fitbit’s Losses

By Mark R. Hake, CFA
Investors will eventually grow tired of Fitbit's losses and zero profit outlook. Fitbit stock has no chance of rising until it can produce higher revenue and positive FCF despite growing competition.
Load More Articles